Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAM.C. Liu, David R. Spigel, Alexander S. Parker et al.|Annals of Oncology|2020Cited by 1.5k
The <i>FGFR3</i> Mutation is Related to Favorable pT1 Bladder CancerBas W.G. van Rhijn, Bharati Bapat, Theodorus van der Kwast et al.|The Journal of Urology|2011Cited by 102
Prognostic value of molecular markers, sub‐stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancerBas W.G. van Rhijn, Alexandre R. Zlotta, Liyang Liu et al.|British Journal of Urology|2012Cited by 64
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort studyJethro C.C. Kwong, Alexandre R. Zlotta, Adree Khondker et al.|The Lancet Digital Health|2023Cited by 16
308 THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCERBas W.G. van Rhijn, Alexandre R. Zlotta, Bharati Bapat et al.|European Urology Supplements|2009Cited by 12